Literature DB >> 9168983

Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product.

R Nagai1, K Ikeda, T Higashi, H Sano, Y Jinnouchi, T Araki, S Horiuchi.   

Abstract

Recent studies demonstrated N epsilon-(carboxymethyl)lysine (CML) in several tissue proteins. Incubation of proteins with glucose leads through a Schiff base to Amadori products. Oxidative cleavage of Amadori products is considered as a major route to CML formation in vivo, whereas it is not known which reactive oxygen species (ROS) is involved. The present study is undertaken to identify such a ROS. We prepared heavily glycated human serum albumin (HSA) which contained a high level of Amadori products, but an undetectable level of CML. Incubation of glycated HSA with FeCl2, but not with H2O2, led to CML formation which was enhanced by H2O2, but inhibited by catalase or mannitol, whereas superoxide dismutase had no effect. Similar data were obtained by experiments using Boc-fructose-lysine as a model Amadori compound. These data indicate that hydroxyl radical generated by the reaction of Fe2+ with H2O2 mediates CML formation from Amadori compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168983     DOI: 10.1006/bbrc.1997.6608

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Transition metals redox: reviving an old plot for diabetic vascular disease.

Authors:  V M Monnier
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis.

Authors:  T Matsuse; E Ohga; S Teramoto; M Fukayama; R Nagai; S Horiuchi; Y Ouchi
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

3.  Modulation of advanced glycation endproduct synthesis by kynurenines in human lens proteins.

Authors:  Ram H Nagaraj; Smitha Padmanabha; Maneesh Mailankot; Magdalena Staniszewska; Liew Jun Mun; Marcus A Glomb; Mikhail D Linetsky
Journal:  Biochim Biophys Acta       Date:  2009-12-22

Review 4.  Antibody-based detection of advanced glycation end-products: promises vs. limitations.

Authors:  Ryoji Nagai; Jun-Ichi Shirakawa; Rei-Ichi Ohno; Kota Hatano; Hikari Sugawa; Shoutaro Arakawa; Kenta Ichimaru; Shoh Kinoshita; Noriyuki Sakata; Mime Nagai
Journal:  Glycoconj J       Date:  2016-07-15       Impact factor: 2.916

Review 5.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 6.  Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease.

Authors:  Naoyuki Taniguchi; Motoko Takahashi; Yasuhiko Kizuka; Shinobu Kitazume; Vladimir V Shuvaev; Tomomi Ookawara; Akiko Furuta
Journal:  Glycoconj J       Date:  2016-06-21       Impact factor: 2.916

Review 7.  Atherosclerosis and restenosis: is there a role for RAGE?

Authors:  Peter Nawroth; Angelika Bierhaus; Mario Marrero; Hiroshi Yamamoto; David M Stern
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

8.  Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.

Authors:  Saul Genuth; Wanjie Sun; Patricia Cleary; David R Sell; William Dahms; John Malone; William Sivitz; Vincent M Monnier
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

9.  NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy.

Authors:  Nik M Mustapha; Joanna M Tarr; Eva M Kohner; Rakesh Chibber
Journal:  J Ophthalmol       Date:  2010-06-28       Impact factor: 1.909

Review 10.  EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.

Authors:  Pamela Ouyang; Sheldon H Gottlieb; Valerie L Culotta; Ana Navas-Acien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.